About Saitama Medical University Hospital
Clinical Trials at Saitama Medical University Hospital
During the past decade, Saitama Medical University Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Saitama Medical University Hospital" #1 sponsor was "Bristol-Myers Squibb" with 1 trials, followed by "Chugai Pharmaceutical" with 1 trials
sponsored, "Genmab" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Incyte Corporation"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Saitama Medical University Hospital"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "Japan Lung Cancer Society" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Saitama Medical University Hospital
According to Clinical.Site data, the most researched conditions in "Saitama Medical University Hospital" are
"Atypical Hemolytic Uremic Syndrome" (1 trials), "Cancer, Hepatocellular" (1 trials), "Crohn's Disease" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "Follicular Lymphoma" (1 trials). Many other conditions were trialed in "Saitama Medical University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Saitama Medical University Hospital
Most popular intervention types in "Saitama Medical University Hospital" are "Drug" (5 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Crovalimab" (1 trials), "Epcoritamab" (1 trials), "Guselkumab" (1 trials), "Guselkumab Dose 1" (1 trials) and "Guselkumab Dose 2" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Saitama Medical University Hospital
The vast majority of trials in "Saitama Medical University Hospital" are
6 trials for "All" genders.
Clinical Trials Status at Saitama Medical University Hospital
Currently, there are NaN active trials in "Saitama Medical University Hospital".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Saitama Medical University Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Saitama Medical University Hospital, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Saitama Medical University Hospital
Saitama Medical University Hospital has several departments that took part in Clinical trials: "Saitama Children's Medical Center" - 19 trials, "Saitama Cancer Center; Thoracic Oncology" - 7 trials, "Saitama Cancer Center, Breast Oncology" - 6 trials, "Saitama Cancer Center; Gastroenterology" - 4 trials, "Saitama Medical University International Medical Center - Dept of Respiratory Medicine" - 2 trials